Pinnbrook Capital Management LP Purchases New Holdings in Merck & Co., Inc. $MRK

robot
摘要生成中

Pinnbrook Capital Management LP has acquired a new stake of 11,925 shares in Merck & Co., Inc. worth approximately $1.00 million during the third quarter. Merck (NYSE: MRK) recently exceeded quarterly earnings estimates and provided optimistic FY 2026 guidance, leading to a “Moderate Buy” consensus rating from analysts with an average price target of $126.81. While institutional ownership remains high at 76.07%, insiders have sold a significant amount of shares totaling $38.3 million over the past 90 days.

此页面可能包含第三方内容,仅供参考(非陈述/保证),不应被视为 Gate 认可其观点表述,也不得被视为财务或专业建议。详见声明
  • 赞赏
  • 评论
  • 转发
  • 分享
评论
请输入评论内容
请输入评论内容
暂无评论